Feliza Mirasol

Feliza Mirasol is the science editor for BioPharm International.


Development of Bispecific Antibodies Pushes Forward

The recent approvals of bispecific antibodies have opened the gate for the further development of these complex molecules.

Adopting a Modeling Approach for Preclinical Studies

One can use modeling methods to generate data and shorten development timelines in preclinical studies.